Review



11β hydroxytestosterone 11oht  (steraloids inc)


Bioz Verified Symbol steraloids inc is a verified supplier
Bioz Manufacturer Symbol steraloids inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    steraloids inc 11β hydroxytestosterone 11oht
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11β Hydroxytestosterone 11oht, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/bio_rxiv__64898__2026__03__27__714735-107-14-22
    Average 93 stars, based on 20 article reviews
    11β hydroxytestosterone 11oht - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women"

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

    Journal: bioRxiv

    doi: 10.64898/2026.03.27.714735

    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    Figure Legend Snippet: Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).

    Techniques Used: Incubation, Liquid Chromatography with Mass Spectroscopy

    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A & B ) bariatric surgery (n=8, age 32-59, BMI 42.0-56.8 kg/m ) and ( C & D ) gynecological surgery (n=22, age 36-63, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynae surgery). Androgen metabolites were quantified by LC-MS/MS. ( E ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT; n=8 or 9). Bars show the mean of all independent experiments ± IQR; circles represent the results in individual adipose tissue explants ( A-D ) or independent cell culture experiments ( E ).
    Figure Legend Snippet: Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A & B ) bariatric surgery (n=8, age 32-59, BMI 42.0-56.8 kg/m ) and ( C & D ) gynecological surgery (n=22, age 36-63, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynae surgery). Androgen metabolites were quantified by LC-MS/MS. ( E ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT; n=8 or 9). Bars show the mean of all independent experiments ± IQR; circles represent the results in individual adipose tissue explants ( A-D ) or independent cell culture experiments ( E ).

    Techniques Used: Incubation, Liquid Chromatography with Mass Spectroscopy, Cell Culture

    ( A ) Inhibitor dose-response curves of AKR1C3 activity for the A4 to T and 11KA4 to 11KT reactions. HEK293T cells were transfected to express AKR1C3 and treated with either A4 or 11KA4 (100 nM) and increasing concentration of the AKR1C3 inhibitor BAY2299242 (BAY2) (n=3). Mean values with SEM as percentage of uninhibited activity are shown. A non-linear fit with the Four-Parameter Logistic (4PL) regression model with the slope parameter set to 1 was made to the model and the sigmoidal curve displays the 100% + response value with a 95% confidence interval. ( B & C ) A luciferase reporter assay in HEK293 cells transfected to constitutively express AKR1C3 and the AR, as well as luciferase under the control of an androgen response element, shows that AKR1C3 inhibition with BAY2 blocks AR transactivation in response to A4 and 11KA4 (n=4). Mean and SEM are shown. P-values were determined with a paired, two-tailed t-test. ( D & E ) Selective inhibition of 11-oxygenated androgen activation with BAY2 (300 nM) in female subcutaneous or visceral adipose tissue (n=22 donors, age 36-63, BMI 20.8-38.2 kg m - ) incubated ex vivo with androstenedione or 11KA4 (100 nM). Bars show the mean of all independent replicates ± SEM; circles represent the individual tissue donors. P-values were determined using Wilcoxon matched-pairs signed rank test. ( F & G ) In silico prediction of AKR1C3 inhibition in adipose tissue shows. A computational model of adipose tissue androgen metabolism by AKR1C3 and HSD11B1 was fitted to the experimental conversion data from the ex vivo subcutaneous ( F ) and visceral ( G ) adipose experiments from D & E in the absence of the AKR1C3 inhibitor (n=22). The reduction in AKR1C3 activity up to its fitted level of inhibition was then simulated and compared to the inhibition achieved in the ex vivo experiments with 300 nM BAY2 for each individual donor. The experimental data is shown as individual data points (open circles), while the model’s simulations of increasing AKR1C3 inhibition are shown by the connecting black lines. The colored lines and shaded areas show the median and median absolute deviation of the model’s predictions. The data is shown as the ratio of AKR1C3 substrates over total classic (A4 / (A4 + T) or 11-oxygenated androgens (11KT + 11OHT) / (11OHA4 + 11KA4 + 11KT + 11OHT)).
    Figure Legend Snippet: ( A ) Inhibitor dose-response curves of AKR1C3 activity for the A4 to T and 11KA4 to 11KT reactions. HEK293T cells were transfected to express AKR1C3 and treated with either A4 or 11KA4 (100 nM) and increasing concentration of the AKR1C3 inhibitor BAY2299242 (BAY2) (n=3). Mean values with SEM as percentage of uninhibited activity are shown. A non-linear fit with the Four-Parameter Logistic (4PL) regression model with the slope parameter set to 1 was made to the model and the sigmoidal curve displays the 100% + response value with a 95% confidence interval. ( B & C ) A luciferase reporter assay in HEK293 cells transfected to constitutively express AKR1C3 and the AR, as well as luciferase under the control of an androgen response element, shows that AKR1C3 inhibition with BAY2 blocks AR transactivation in response to A4 and 11KA4 (n=4). Mean and SEM are shown. P-values were determined with a paired, two-tailed t-test. ( D & E ) Selective inhibition of 11-oxygenated androgen activation with BAY2 (300 nM) in female subcutaneous or visceral adipose tissue (n=22 donors, age 36-63, BMI 20.8-38.2 kg m - ) incubated ex vivo with androstenedione or 11KA4 (100 nM). Bars show the mean of all independent replicates ± SEM; circles represent the individual tissue donors. P-values were determined using Wilcoxon matched-pairs signed rank test. ( F & G ) In silico prediction of AKR1C3 inhibition in adipose tissue shows. A computational model of adipose tissue androgen metabolism by AKR1C3 and HSD11B1 was fitted to the experimental conversion data from the ex vivo subcutaneous ( F ) and visceral ( G ) adipose experiments from D & E in the absence of the AKR1C3 inhibitor (n=22). The reduction in AKR1C3 activity up to its fitted level of inhibition was then simulated and compared to the inhibition achieved in the ex vivo experiments with 300 nM BAY2 for each individual donor. The experimental data is shown as individual data points (open circles), while the model’s simulations of increasing AKR1C3 inhibition are shown by the connecting black lines. The colored lines and shaded areas show the median and median absolute deviation of the model’s predictions. The data is shown as the ratio of AKR1C3 substrates over total classic (A4 / (A4 + T) or 11-oxygenated androgens (11KT + 11OHT) / (11OHA4 + 11KA4 + 11KT + 11OHT)).

    Techniques Used: Activity Assay, Transfection, Concentration Assay, Luciferase, Reporter Assay, Control, Inhibition, Two Tailed Test, Activation Assay, Incubation, Ex Vivo, In Silico

    ( A ) Schematic showing the AKR1C3-catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum concentrations of testosterone, 11-ketotestosterone and 11β-hydroxytestosterone over the 12 weeks of treatment with either 60 mg BAY1128688 (BAY1) taken orally twice daily (n=9) or placebo (n=12). Panels B-D show the acute androgen response to BAY1 and placebo within 4 hours of oral intake of inhibitor or placebo at baseline (=first dose) and after 12 weeks of treatment with no effect on testosterone but decreases in the circulating concentrations of 11KT and 11OHT at 2 and 4 hours. Panels E-G show the morning serum concentrations of active androgens during the 12-week treatment period and 6 weeks after the end of treatment (=EoT) with the AKR1C3 inhibitor or placebo. Serum steroid levels were quantified by LC-MS/MS. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25 th -75 th percentile, whiskers the range. Circles represent the individual participants. The dotted line indicates the lower limit of quantification for the respective analyte.
    Figure Legend Snippet: ( A ) Schematic showing the AKR1C3-catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum concentrations of testosterone, 11-ketotestosterone and 11β-hydroxytestosterone over the 12 weeks of treatment with either 60 mg BAY1128688 (BAY1) taken orally twice daily (n=9) or placebo (n=12). Panels B-D show the acute androgen response to BAY1 and placebo within 4 hours of oral intake of inhibitor or placebo at baseline (=first dose) and after 12 weeks of treatment with no effect on testosterone but decreases in the circulating concentrations of 11KT and 11OHT at 2 and 4 hours. Panels E-G show the morning serum concentrations of active androgens during the 12-week treatment period and 6 weeks after the end of treatment (=EoT) with the AKR1C3 inhibitor or placebo. Serum steroid levels were quantified by LC-MS/MS. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25 th -75 th percentile, whiskers the range. Circles represent the individual participants. The dotted line indicates the lower limit of quantification for the respective analyte.

    Techniques Used: Liquid Chromatography with Mass Spectroscopy

    Women received either 60 mg BAY1 twice daily (n=9) or placebo (n=12). (A) Schematic showing the AKR1C3 catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum levels of (B-E) 11-oxygenated androgens and (F-J) classic androgens quantified by LC-MS/MS show acute decreases in the active 11-oxygenated androgens (11KT and 11OHT, D & E) without discernible acute effect on classic androgens. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25th-75th percentile, whiskers the range. Closed circles represent the individual participants. The dotted line indicates the lower limit of quantification of the LC-MS/MS assay.
    Figure Legend Snippet: Women received either 60 mg BAY1 twice daily (n=9) or placebo (n=12). (A) Schematic showing the AKR1C3 catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum levels of (B-E) 11-oxygenated androgens and (F-J) classic androgens quantified by LC-MS/MS show acute decreases in the active 11-oxygenated androgens (11KT and 11OHT, D & E) without discernible acute effect on classic androgens. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25th-75th percentile, whiskers the range. Closed circles represent the individual participants. The dotted line indicates the lower limit of quantification of the LC-MS/MS assay.

    Techniques Used: Liquid Chromatography with Mass Spectroscopy

    Related Articles

    Incubation:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Liquid Chromatography with Mass Spectroscopy:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Cell Culture:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Activity Assay:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Transfection:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Concentration Assay:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Luciferase:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Reporter Assay:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Control:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Inhibition:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Two Tailed Test:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Activation Assay:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Ex Vivo:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    In Silico:

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women
    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.



    Similar Products

    93
    steraloids inc 11β hydroxytestosterone 11oht
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11β Hydroxytestosterone 11oht, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/bio_rxiv__64898__2026__03__27__714735-107-14-22
    Average 93 stars, based on 1 article reviews
    11β hydroxytestosterone 11oht - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc 11β hydroxyandrostenedione
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11β Hydroxyandrostenedione, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-9-14
    Average 93 stars, based on 1 article reviews
    11β hydroxyandrostenedione - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc 11oht
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11oht, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-5-14
    Average 93 stars, based on 1 article reviews
    11oht - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc 11kt
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11kt, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-3-14
    Average 93 stars, based on 1 article reviews
    11kt - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc ketoandrostenedione
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    Ketoandrostenedione, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-6-14
    Average 93 stars, based on 1 article reviews
    ketoandrostenedione - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc analytes 11 ketotestosterone
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    Analytes 11 Ketotestosterone, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-1-14
    Average 93 stars, based on 1 article reviews
    analytes 11 ketotestosterone - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc 11β hydroxytestosterone
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11β Hydroxytestosterone, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-4-14
    Average 93 stars, based on 1 article reviews
    11β hydroxytestosterone - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc 11ka4
    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and <t>11OHT)</t> over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).
    11ka4, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm41649750-62-7-14
    Average 93 stars, based on 1 article reviews
    11ka4 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    steraloids inc 11β hydroxy testosterone
    Fig. 1. : Serum concentrations of classic androgens (A) and 11-oxyandrogens (B) in healthy premenopausal women during proliferative (n=12) and secretory (n=17) menstrual phases. Data is represented as boxplots showing median, 1st and 3rd quartiles, whiskers as min-max values and raw data as individual dots; samples below the LLOQ are represented as LLOQ/2 and are shown as white dots. Statistical test used: Mann-Whitney U test in A-B; *p<0.05; **p<0.01. 11OHA4, <t>11β-hydrox</t> yandrostenedione; 11KA4, 11-ketoandrostenedione; <t>11OHT,</t> 11β-hydroxytestosterone; 11KT, 11-ketotestosterone; A4, androstenedione; DHEA, dehydroepiandros terone; DHT, 5α-dihydrotestosterone; T, testosterone.
    11β Hydroxy Testosterone, supplied by steraloids inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/A5760-000/4-ANDROSTEN-11%CE%B2%2C+17%CE%B2-DIOL-3-ONE/pm38971335-34-14-35
    Average 93 stars, based on 1 article reviews
    11β hydroxy testosterone - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).

    Journal: bioRxiv

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

    doi: 10.64898/2026.03.27.714735

    Figure Lengend Snippet: Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A ) bariatric surgery (n=8, age 32-59 yrs, BMI 42.0-56.8 kg/m ) and ( B ) gynecological surgery (n=22, age 36-63 yrs, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynecological surgery). Androgen metabolites were quantified by LC-MS/MS. ( C ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT) (n=8 or 9). Bars show the mean of all independent experiments ± SEM; circles represent the individual tissue donors (A and B) or independent experiments (C).

    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Techniques: Incubation, Liquid Chromatography with Mass Spectroscopy

    Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A & B ) bariatric surgery (n=8, age 32-59, BMI 42.0-56.8 kg/m ) and ( C & D ) gynecological surgery (n=22, age 36-63, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynae surgery). Androgen metabolites were quantified by LC-MS/MS. ( E ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT; n=8 or 9). Bars show the mean of all independent experiments ± IQR; circles represent the results in individual adipose tissue explants ( A-D ) or independent cell culture experiments ( E ).

    Journal: bioRxiv

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

    doi: 10.64898/2026.03.27.714735

    Figure Lengend Snippet: Incubations of subcutaneous and visceral adipose tissue showed preferential generation of active 11-oxygenated androgens (11KT and 11OHT) over the classic androgen (T). Adipose tissue was collected from women undergoing ( A & B ) bariatric surgery (n=8, age 32-59, BMI 42.0-56.8 kg/m ) and ( C & D ) gynecological surgery (n=22, age 36-63, BMI 20.8-38.2 kg/m ) and incubated with the AKR1C3 substrates androstenedione or 11KA4 (100 nM) for 72h (bariatric surgery) or 24h (gynae surgery). Androgen metabolites were quantified by LC-MS/MS. ( E ) Incubation of differentiated SGBS adipocytes with A4 or 11KA4 (100 nM) results in greater generation of the active classic androgen (T) compared to the 11-oxygenated androgens (11KT and 11OHT; n=8 or 9). Bars show the mean of all independent experiments ± IQR; circles represent the results in individual adipose tissue explants ( A-D ) or independent cell culture experiments ( E ).

    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Techniques: Incubation, Liquid Chromatography with Mass Spectroscopy, Cell Culture

    ( A ) Inhibitor dose-response curves of AKR1C3 activity for the A4 to T and 11KA4 to 11KT reactions. HEK293T cells were transfected to express AKR1C3 and treated with either A4 or 11KA4 (100 nM) and increasing concentration of the AKR1C3 inhibitor BAY2299242 (BAY2) (n=3). Mean values with SEM as percentage of uninhibited activity are shown. A non-linear fit with the Four-Parameter Logistic (4PL) regression model with the slope parameter set to 1 was made to the model and the sigmoidal curve displays the 100% + response value with a 95% confidence interval. ( B & C ) A luciferase reporter assay in HEK293 cells transfected to constitutively express AKR1C3 and the AR, as well as luciferase under the control of an androgen response element, shows that AKR1C3 inhibition with BAY2 blocks AR transactivation in response to A4 and 11KA4 (n=4). Mean and SEM are shown. P-values were determined with a paired, two-tailed t-test. ( D & E ) Selective inhibition of 11-oxygenated androgen activation with BAY2 (300 nM) in female subcutaneous or visceral adipose tissue (n=22 donors, age 36-63, BMI 20.8-38.2 kg m - ) incubated ex vivo with androstenedione or 11KA4 (100 nM). Bars show the mean of all independent replicates ± SEM; circles represent the individual tissue donors. P-values were determined using Wilcoxon matched-pairs signed rank test. ( F & G ) In silico prediction of AKR1C3 inhibition in adipose tissue shows. A computational model of adipose tissue androgen metabolism by AKR1C3 and HSD11B1 was fitted to the experimental conversion data from the ex vivo subcutaneous ( F ) and visceral ( G ) adipose experiments from D & E in the absence of the AKR1C3 inhibitor (n=22). The reduction in AKR1C3 activity up to its fitted level of inhibition was then simulated and compared to the inhibition achieved in the ex vivo experiments with 300 nM BAY2 for each individual donor. The experimental data is shown as individual data points (open circles), while the model’s simulations of increasing AKR1C3 inhibition are shown by the connecting black lines. The colored lines and shaded areas show the median and median absolute deviation of the model’s predictions. The data is shown as the ratio of AKR1C3 substrates over total classic (A4 / (A4 + T) or 11-oxygenated androgens (11KT + 11OHT) / (11OHA4 + 11KA4 + 11KT + 11OHT)).

    Journal: bioRxiv

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

    doi: 10.64898/2026.03.27.714735

    Figure Lengend Snippet: ( A ) Inhibitor dose-response curves of AKR1C3 activity for the A4 to T and 11KA4 to 11KT reactions. HEK293T cells were transfected to express AKR1C3 and treated with either A4 or 11KA4 (100 nM) and increasing concentration of the AKR1C3 inhibitor BAY2299242 (BAY2) (n=3). Mean values with SEM as percentage of uninhibited activity are shown. A non-linear fit with the Four-Parameter Logistic (4PL) regression model with the slope parameter set to 1 was made to the model and the sigmoidal curve displays the 100% + response value with a 95% confidence interval. ( B & C ) A luciferase reporter assay in HEK293 cells transfected to constitutively express AKR1C3 and the AR, as well as luciferase under the control of an androgen response element, shows that AKR1C3 inhibition with BAY2 blocks AR transactivation in response to A4 and 11KA4 (n=4). Mean and SEM are shown. P-values were determined with a paired, two-tailed t-test. ( D & E ) Selective inhibition of 11-oxygenated androgen activation with BAY2 (300 nM) in female subcutaneous or visceral adipose tissue (n=22 donors, age 36-63, BMI 20.8-38.2 kg m - ) incubated ex vivo with androstenedione or 11KA4 (100 nM). Bars show the mean of all independent replicates ± SEM; circles represent the individual tissue donors. P-values were determined using Wilcoxon matched-pairs signed rank test. ( F & G ) In silico prediction of AKR1C3 inhibition in adipose tissue shows. A computational model of adipose tissue androgen metabolism by AKR1C3 and HSD11B1 was fitted to the experimental conversion data from the ex vivo subcutaneous ( F ) and visceral ( G ) adipose experiments from D & E in the absence of the AKR1C3 inhibitor (n=22). The reduction in AKR1C3 activity up to its fitted level of inhibition was then simulated and compared to the inhibition achieved in the ex vivo experiments with 300 nM BAY2 for each individual donor. The experimental data is shown as individual data points (open circles), while the model’s simulations of increasing AKR1C3 inhibition are shown by the connecting black lines. The colored lines and shaded areas show the median and median absolute deviation of the model’s predictions. The data is shown as the ratio of AKR1C3 substrates over total classic (A4 / (A4 + T) or 11-oxygenated androgens (11KT + 11OHT) / (11OHA4 + 11KA4 + 11KT + 11OHT)).

    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Techniques: Activity Assay, Transfection, Concentration Assay, Luciferase, Reporter Assay, Control, Inhibition, Two Tailed Test, Activation Assay, Incubation, Ex Vivo, In Silico

    ( A ) Schematic showing the AKR1C3-catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum concentrations of testosterone, 11-ketotestosterone and 11β-hydroxytestosterone over the 12 weeks of treatment with either 60 mg BAY1128688 (BAY1) taken orally twice daily (n=9) or placebo (n=12). Panels B-D show the acute androgen response to BAY1 and placebo within 4 hours of oral intake of inhibitor or placebo at baseline (=first dose) and after 12 weeks of treatment with no effect on testosterone but decreases in the circulating concentrations of 11KT and 11OHT at 2 and 4 hours. Panels E-G show the morning serum concentrations of active androgens during the 12-week treatment period and 6 weeks after the end of treatment (=EoT) with the AKR1C3 inhibitor or placebo. Serum steroid levels were quantified by LC-MS/MS. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25 th -75 th percentile, whiskers the range. Circles represent the individual participants. The dotted line indicates the lower limit of quantification for the respective analyte.

    Journal: bioRxiv

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

    doi: 10.64898/2026.03.27.714735

    Figure Lengend Snippet: ( A ) Schematic showing the AKR1C3-catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum concentrations of testosterone, 11-ketotestosterone and 11β-hydroxytestosterone over the 12 weeks of treatment with either 60 mg BAY1128688 (BAY1) taken orally twice daily (n=9) or placebo (n=12). Panels B-D show the acute androgen response to BAY1 and placebo within 4 hours of oral intake of inhibitor or placebo at baseline (=first dose) and after 12 weeks of treatment with no effect on testosterone but decreases in the circulating concentrations of 11KT and 11OHT at 2 and 4 hours. Panels E-G show the morning serum concentrations of active androgens during the 12-week treatment period and 6 weeks after the end of treatment (=EoT) with the AKR1C3 inhibitor or placebo. Serum steroid levels were quantified by LC-MS/MS. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25 th -75 th percentile, whiskers the range. Circles represent the individual participants. The dotted line indicates the lower limit of quantification for the respective analyte.

    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Techniques: Liquid Chromatography with Mass Spectroscopy

    Women received either 60 mg BAY1 twice daily (n=9) or placebo (n=12). (A) Schematic showing the AKR1C3 catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum levels of (B-E) 11-oxygenated androgens and (F-J) classic androgens quantified by LC-MS/MS show acute decreases in the active 11-oxygenated androgens (11KT and 11OHT, D & E) without discernible acute effect on classic androgens. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25th-75th percentile, whiskers the range. Closed circles represent the individual participants. The dotted line indicates the lower limit of quantification of the LC-MS/MS assay.

    Journal: bioRxiv

    Article Title: Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

    doi: 10.64898/2026.03.27.714735

    Figure Lengend Snippet: Women received either 60 mg BAY1 twice daily (n=9) or placebo (n=12). (A) Schematic showing the AKR1C3 catalyzed conversions for 11-oxygenated androgens (red) and classic androgens (blue). Serum levels of (B-E) 11-oxygenated androgens and (F-J) classic androgens quantified by LC-MS/MS show acute decreases in the active 11-oxygenated androgens (11KT and 11OHT, D & E) without discernible acute effect on classic androgens. The arrow indicates the timing of inhibitor or placebo administration. Boxes show the median and 25th-75th percentile, whiskers the range. Closed circles represent the individual participants. The dotted line indicates the lower limit of quantification of the LC-MS/MS assay.

    Article Snippet: 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), androstenedione (A4) and testosterone (T) were purchased from Sigma-Aldrich, while 11β-hydroxytestosterone (11OHT) and 11-ketotestosterone (11KT) were obtained from Steraloids.

    Techniques: Liquid Chromatography with Mass Spectroscopy

    Fig. 1. : Serum concentrations of classic androgens (A) and 11-oxyandrogens (B) in healthy premenopausal women during proliferative (n=12) and secretory (n=17) menstrual phases. Data is represented as boxplots showing median, 1st and 3rd quartiles, whiskers as min-max values and raw data as individual dots; samples below the LLOQ are represented as LLOQ/2 and are shown as white dots. Statistical test used: Mann-Whitney U test in A-B; *p<0.05; **p<0.01. 11OHA4, 11β-hydrox yandrostenedione; 11KA4, 11-ketoandrostenedione; 11OHT, 11β-hydroxytestosterone; 11KT, 11-ketotestosterone; A4, androstenedione; DHEA, dehydroepiandros terone; DHT, 5α-dihydrotestosterone; T, testosterone.

    Journal: The Journal of steroid biochemistry and molecular biology

    Article Title: Simultaneous measurement of 17 endogenous steroid hormones in human serum by liquid chromatography-tandem mass spectrometry without derivatization.

    doi: 10.1016/j.jsbmb.2024.106578

    Figure Lengend Snippet: Fig. 1. : Serum concentrations of classic androgens (A) and 11-oxyandrogens (B) in healthy premenopausal women during proliferative (n=12) and secretory (n=17) menstrual phases. Data is represented as boxplots showing median, 1st and 3rd quartiles, whiskers as min-max values and raw data as individual dots; samples below the LLOQ are represented as LLOQ/2 and are shown as white dots. Statistical test used: Mann-Whitney U test in A-B; *p<0.05; **p<0.01. 11OHA4, 11β-hydrox yandrostenedione; 11KA4, 11-ketoandrostenedione; 11OHT, 11β-hydroxytestosterone; 11KT, 11-ketotestosterone; A4, androstenedione; DHEA, dehydroepiandros terone; DHT, 5α-dihydrotestosterone; T, testosterone.

    Article Snippet: Androstenedione (A4; Chemical Abstracts Service (CAS) number: 63–05–8; #A6030–000), dihydrotestosterone (DHT; CAS: 521–18–6; #A2579–000), 11β-hydroxy-testosterone (11OHT; CAS: 1816–85–9; #A5760–000), 11β-hydroxy-progesterone (11OHP4, CAS: 600–57–7; #Q3270–000), 11-keto-progesterone (11KP4; CAS: 516–15–4; #Q4160–000), 11-deoxycortisol (CAS: 152–58–9; #Q1610) were from Steraloids.

    Techniques: MANN-WHITNEY

    Fig. 2. : Serum concentrations of progestogens (A), mineralocorticoids (B) and glucocorticoids (C) in healthy premenopausal women during proliferative (n=12) and secretory (n=17) menstrual phases. Data is represented as boxplots showing median, 1st and 3rd quartiles, whiskers as min-max values and raw data as individual dots; samples below the LLOQ are represented as LLOQ/2 and are shown as white dots. Statistical test used: Mann-Whitney U test in A-C; *p<0.05; **p<0.01. 11OHP4, 11β-hydroxyprogesterone; 11KP4, 11-keto-progesterone; 17OHP4, 17α-hydroxy-progesterone; P4, progesterone.

    Journal: The Journal of steroid biochemistry and molecular biology

    Article Title: Simultaneous measurement of 17 endogenous steroid hormones in human serum by liquid chromatography-tandem mass spectrometry without derivatization.

    doi: 10.1016/j.jsbmb.2024.106578

    Figure Lengend Snippet: Fig. 2. : Serum concentrations of progestogens (A), mineralocorticoids (B) and glucocorticoids (C) in healthy premenopausal women during proliferative (n=12) and secretory (n=17) menstrual phases. Data is represented as boxplots showing median, 1st and 3rd quartiles, whiskers as min-max values and raw data as individual dots; samples below the LLOQ are represented as LLOQ/2 and are shown as white dots. Statistical test used: Mann-Whitney U test in A-C; *p<0.05; **p<0.01. 11OHP4, 11β-hydroxyprogesterone; 11KP4, 11-keto-progesterone; 17OHP4, 17α-hydroxy-progesterone; P4, progesterone.

    Article Snippet: Androstenedione (A4; Chemical Abstracts Service (CAS) number: 63–05–8; #A6030–000), dihydrotestosterone (DHT; CAS: 521–18–6; #A2579–000), 11β-hydroxy-testosterone (11OHT; CAS: 1816–85–9; #A5760–000), 11β-hydroxy-progesterone (11OHP4, CAS: 600–57–7; #Q3270–000), 11-keto-progesterone (11KP4; CAS: 516–15–4; #Q4160–000), 11-deoxycortisol (CAS: 152–58–9; #Q1610) were from Steraloids.

    Techniques: MANN-WHITNEY